The tumor suppressor DAPK is reciprocally regulated by tyrosine kinase Src and phosphatase LAR

Won-Jing Wang1, Jean-Cheng Kuo, Wei Ku

  • 1Institute of Biological Chemistry, Academia Sinica, Taipei 115, Taiwan.

Molecular Cell
|September 7, 2007
PubMed

Insights

Leukocyte common antigen-related tyrosine phosphatase (LAR) dephosphorylates Death-associated protein kinase (DAPK), enhancing its tumor-suppressing activity. Conversely, Src kinase inactivates DAPK, promoting cancer cell migration and invasion.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Death-associated protein kinase (DAPK) is a serine/threonine kinase with tumor suppressor functions, inhibiting cell adhesion/migration and promoting apoptosis.
  • The precise regulatory mechanisms governing DAPK activity remain largely unknown.

Purpose of the Study:

  • To elucidate the signaling pathways regulating DAPK activity.
  • To investigate the roles of leukocyte common antigen-related tyrosine phosphatase (LAR) and Src kinase in DAPK regulation.
  • To establish a link between DAPK regulation and tumor progression.

Main Methods:

  • Investigated the phosphorylation status of DAPK at Y491/492.
  • Utilized biochemical assays to assess DAPK activity, dephosphorylation by LAR, and phosphorylation by Src.
  • Examined the effects of EGF stimulation on Src, LAR, and DAPK activity in cancer cells.
  • Analyzed DAPK phosphorylation in human cancer tissues.

Main Results:

  • LAR tyrosine phosphatase dephosphorylates DAPK at pY491/492, stimulating its catalytic, proapoptotic, and antiadhesion/antimigration activities.
  • Src kinase phosphorylates DAPK at Y491/492, leading to its inactivation.
  • EGF stimulation activates Src and downregulates LAR, synergistically inactivating DAPK and promoting tumor cell migration.
  • DAPK Y491/492 hyperphosphorylation correlates with elevated Src activity in human cancers.

Conclusions:

  • LAR and Src act as key regulators of DAPK through reciprocal phosphorylation/dephosphorylation at Y491/492.
  • This DAPK-regulatory circuit involving LAR and Src plays a critical role in facilitating tumor cell migration, invasion, and overall cancer progression.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...